Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-019 - Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Alexander Spira | Author(s): David Spigel, Ross Camidge, Adrianus J de Langen, Tae Min Kim, Koichi Goto, Yasir Elamin, Elaine Shum, Karen Reckamp, Julia Rotow, Sarah B. Goldberg, Shirish Gadgeel, Ticiana Leal, Faris Albayya, Sarah Fitzpatrick, Melinda Louie-Gao, Jagan Parepally, Alena Zalutskaya, Helena A. Yu- Abstract
Loading... -
+
EP08.02-045 - Phase 1/2 Study of BLU-945 in Patients With Common Activating EGFR-Mutant Non-Small Cell Lung Cancer
Presenter: Elaine Shum | Author(s): Yasir Elamin, Zofia Piotrowska, David Spigel, Karen Reckamp, Julia Rotow, Daniel SW Tan, Sun Min Lim, Tae Min Kim, Chia-Chi Lin, Terufumi Kato, Jagan Parepally, Faris Albayya, Melinda Louie-Gao, Tessa Weining, Alena Zalutskaya, Koichi Goto- Abstract
Loading...
-
+
ES28 - Neoadjuvant and Adjuvant Treatment of NSCLC in 2022
- 10:45 - 11:45
- 8/09/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Education Session
- Track: Early Stage Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Systemic Therapy (Multi-Modality Treatment, Immunotherapy, Molecular Targeted Treatments)
- Moderators:Tina Cascone, Mariano Provencio
-
+
ES28.06 - Neoadjuvant EGFR TKI Trials
11:23 - 11:35 | Presenter: Julia Rotow
- Abstract
Loading...
